Works by Ciliberto, G.

Results: 25

Electro-gene-transfer as a new tool for cancer immunotherapy in animals.

Published in:

Veterinary & Comparative Oncology, 2014, v. 12, n. 4, p. 310, doi. 10.1111/vco.12006

By:

Impellizeri, J. A.;
Ciliberto, G.;
Aurisicchio, L.

Publication type:

Article

Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells.

Published in:

Cell Death & Disease, 2013, v. 4, n. 12, p. 1, doi. 10.1038/cddis.2013.444

By:

Noto, A.;
Raffa, S.;
De Vitis, C.;
Roscilli, G.;
Malpicci, D.;
Coluccia, P.;
Di Napoli, A.;
Ricci, A.;
Giovagnoli, M. R.;
Aurisicchio, L.;
Torrisi, M. R.;
Ciliberto, G.;
Mancini, R.

Publication type:

Article

Coronary artery disease after heart transplantation: non-invasive evaluation with exercise thallium scintigraphy.

Published in:

European Heart Journal, 1993, v. 14, n. 2, p. 226, doi. 10.1093/eurheartj/14.2.226

By:

CILIBERTO, G. R.;
MANGIAVACCHI, M.;
BANFI, F.;
MASSA, D.;
DANZI, G.;
CATALDO, G.;
CIPRIANI, M.;
PICCALÒ, G.;
DABALÀ, A.;
GRONDA, E.;
DE VITA, C.

Publication type:

Article

High-dose dipyridamole echocardiography test in coronary artery disease after heart transplantation.

Published in:

European Heart Journal, 1993, v. 14, n. 1, p. 48, doi. 10.1093/eurheartj/14.1.48

By:

CILIBERTO, G. R.;
MASSA, D.;
MANGIAVACCHI, M.;
DANZI, G. B.;
PIRELLI, S.;
FALETRA, F.;
FRIGERIO, M.;
GRONDA, E.;
DE VITA, C.

Publication type:

Article

Echocardiographic assessment of cardiac allograft rejection.

Published in:

European Heart Journal, 1989, v. 10, n. 5, p. 400, doi. 10.1093/oxfordjournals.eurheartj.a059502

By:

CILIBERTO, G. R.;
CATLDO, G.;
CIPRIANI, M.;
MASCARELLO, M.;
FALETRA, F.;
GRONDA, E.;
DE MARIA, R.;
MAURI, L.;
PESSANO, A.

Publication type:

Article

CD8+ T-Cell Tolerance can be Broken by an Adenoviral Vaccine While CD4+ T-Cell Tolerance is Broken by Additional Co-administration of a Toll-Like Receptor Ligand.

Published in:

Scandinavian Journal of Immunology, 2006, v. 63, n. 1, p. 35, doi. 10.1111/j.1365-3083.2006.01706.x

By:

Salucci, V.;
Mennuni, C.;
Calvaruso, F.;
Cerino, R.;
Neuner, P.;
Ciliberto, G.;
La Monica, N.;
Scarselli, E.

Publication type:

Article

Adenovirus Transduction and Culture Conditions Affect the Immunogenicity of Murine Dendritic Cells.

Published in:

Scandinavian Journal of Immunology, 2005, v. 62, n. 3, p. 206, doi. 10.1111/j.1365-3083.2005.01658.x

By:

V. Salucci;
Lena, A. M.;
Ciliberto, G.;
Scarselli, E.;
La Monica, N.

Publication type:

Article

Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015.

Published in:

2016

By:

Galon, J.;
Fox, B. A.;
Bifulco, C. B.;
Masucci, G.;
Rau, T.;
Botti, G.;
Marincola, F. M.;
Ciliberto, G.;
Pages, F.;
Ascierto, P. A.;
Capone, M.

Publication type:

journal article

In vivo hepatocyte proliferation is inducible through a TNF and IL-6-independent pathway.

Published in:

Oncogene, 1998, v. 17, n. 8, p. 1039, doi. 10.1038/sj.onc.1202018

By:

Ledda-Columbano, G. M.;
Curto, M.;
Piga, R.;
Zedda, A. I.;
Menegazzi, M.;
Sartori, C.;
Shinozuka, H.;
Bluethmann, H.;
Poli, V.;
Ciliberto, G.;
Columbano, A.

Publication type:

Article

High circulating levels of biologically inactive IL-6/SIL-6 receptor complexes in systemic juvenile idiopathic arthritis: evidence for serum factors interfering with the binding to gp130.

Published in:

Clinical & Experimental Immunology, 2003, v. 131, n. 2, p. 355, doi. 10.1046/j.1365-2249.2003.02052.x

By:

PIGNATTI, P.;
CIAPPONI, L.;
GALLE, P.;
HANSEN, M. B.;
MASSA, M.;
MEAZZA, C.;
PAONESSA, G.;
NOVICK, D.;
CILIBERTO, G.;
MARTINI, A.;
De BENEDETTI, F.

Publication type:

Article

A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent.

Published in:

Cell Death & Differentiation, 2004, v. 11, p. S2, doi. 10.1038/sj.cdd.4401469

By:

Savino, R.;
Ciliberto, G.

Publication type:

Article

Synergistic induction of growth arrest and apoptosis of human myeloma cells by the IL-6 super-antagonist Sant7 and Dexamethasone.

Published in:

Cell Death & Differentiation, 2000, v. 7, n. 3, p. 327, doi. 10.1038/sj.cdd.4400635

By:

Tassone, P;
Forciniti, S;
Galea, E;
Savino, R;
Turco, M C;
Iacopino, P;
Tagliaferri, P;
Morrone, G;
Ciliberto, G;
Venuta, S

Publication type:

Article

The Molecular Design of Human IL-6 Receptor Antagonistsa.

Published in:

Annals of the New York Academy of Sciences, 1995, v. 762, n. 1, p. 136, doi. 10.1111/j.1749-6632.1995.tb32322.x

By:

LAHM, A.;
SAVINO, R.;
SALVATI, A. L.;
CABIBBO, A.;
CIAPPONI, L.;
DEMARTIS, A.;
TONIATTI, C.;
PAONESSA, G.;
ALTAMURA, S.;
CILIBERTO, G.

Publication type:

Article

Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation.

Published in:

Gene Therapy, 2004, v. 11, n. 8, p. 711, doi. 10.1038/sj.gt.3302213

By:

Wang, Z.;
Troilo, P. J.;
Wang, X.;
Griffiths II, T. G.;
Pacchione, S. J.;
Barnum, A. B.;
Harper, L. B.;
Pauley, C. J.;
Niu, Z.;
Denisova, L.;
Follmer, T. T.;
Rizzuto, G.;
Ciliberto, G.;
Fattori, E.;
Monica, N. L.;
Manam, S.;
Ledwith, B. J.

Publication type:

Article

Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2s-M2 tetracycline transactivator and repressor system.

Published in:

Gene Therapy, 2002, v. 9, n. 21, p. 1415, doi. 10.1038/sj.gt.3301813

By:

Salucci, V;
Scarito, A;
Aurisicchio, L;
Lamartina, S;
Nicolaus, G;
Giampaoli, S;
Gonzalez-Paz, O;
Toniatti, C;
Bujard, H;
Hillen, W;
Ciliberto, G;
Palombo, F

Publication type:

Article

Regulated and prolonged expression of mIFNα in immunocompetent mice mediated by a helper-dependent adenovirus vector.

Published in:

Gene Therapy, 2001, v. 8, n. 24, p. 1817, doi. 10.1038/sj.gt.3301596

By:

Aurisicchio, L;
Bujard, H;
Hillen, W;
Cortese, R;
Ciliberto, G;
La Monica, N;
Palombo, F

Publication type:

Article

Adenovirus-mediated gene transfer of a human IL-6 antagonist.

Published in:

Gene Therapy, 1997, v. 4, n. 8, p. 839, doi. 10.1038/sj.gt.3300467

By:

Saggio, I;
Ciapponi, L;
Savino, R;
Ciliberto, G;
Perricaudet, M

Publication type:

Article

Risk Differences Between Prediabetes And Diabetes According To Breast Cancer Molecular Subtypes.

Published in:

Journal of Cellular Physiology, 2017, v. 232, n. 5, p. 1144, doi. 10.1002/jcp.25579

By:

Crispo, A.;
Augustin, L.S.A.;
Grimaldi, M.;
Nocerino, F.;
Giudice, A.;
Cavalcanti, E.;
Di Bonito, M.;
Botti, G.;
De Laurentiis, M.;
Rinaldo, M.;
Esposito, E.;
Riccardi, G.;
Amore, A.;
Libra, M.;
Ciliberto, G.;
Jenkins, D.J.A.;
Montella, M.

Publication type:

Article

MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study.

Published in:

Biomarker Research, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40364-021-00289-6

By:

Krasniqi, E.;
Sacconi, A.;
Marinelli, D.;
Pizzuti, L.;
Mazzotta, M.;
Sergi, D.;
Capomolla, E.;
Donzelli, S.;
Carosi, M.;
Bagnato, A.;
Gamucci, T.;
Tomao, S.;
Natoli, C.;
Marchetti, P.;
Grassadonia, A.;
Tinari, N.;
De Tursi, M.;
Vizza, E.;
Ciliberto, G.;
Landi, L.

Publication type:

Article

Intratumor RNA interference of cell cycle genes slows down tumor progression.

Published in:

Gene Therapy, 2011, v. 18, n. 7, p. 727, doi. 10.1038/gt.2011.27

By:

Dharmapuri, S;
Peruzzi, D;
Marra, E;
Palombo, F;
Bett, A J;
Bartz, S R;
Yong, M;
Ciliberto, G;
La Monica, N;
Buser, C A;
Toniatti, C;
Aurisicchio, L

Publication type:

Article

Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives.

Published in:

Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0798-2

By:

Krasniqi, E.;
Barchiesi, G.;
Pizzuti, L.;
Mazzotta, M.;
Venuti, A.;
Maugeri-Saccà, M.;
Sanguineti, G.;
Massimiani, G.;
Sergi, D.;
Carpano, S.;
Marchetti, P.;
Tomao, S.;
Gamucci, T.;
De Maria, R.;
Tomao, F.;
Natoli, C.;
Tinari, N.;
Ciliberto, G.;
Barba, M.;
Vici, P.

Publication type:

Article

Validation of the European Oncology toolkit for the self-assessment of Quality of Life (EUonQoL-Kit) in cancer patients and survivors: study protocol of a pan European survey.

Published in:

BMC Public Health, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12889-024-21008-4

By:

Apolone, G.;
Costantini, M.;
Caselli, L.;
Bos, N.;
Caraceni, A.;
Ciliberto, G.;
Couespel, N.;
Ferrer, M.;
Groenvold, M.;
Kaasa, S.;
Lombardo, C.;
Pietrobon, R.;
Pravettoni, G.;
Sirven, A.;
Vachon, H.;
Velikova, G.;
Garin, O.;
Gilbert, A.;
Machiavelli, A.;
Marzorati, C.

Publication type:

Article

Efficacy and safety of 5% lidocaine-medicated plasters in localized pain with neuropathic and/or inflammatory characteristics: an observational, real-world study.

Published in:

European Review for Medical & Pharmacological Sciences, 2017, v. 21, n. 18, p. 4228

By:

AMATO, F.;
DUSE, G.;
CONSOLETTI, L.;
LO PRESTI, C.;
FIRETTO, V.;
CILIBERTO, G.;
PARIGI, L. A.;
PALMIERI, V.;
MAZZA, M.

Publication type:

Article

An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models.

Published in:

Cancer Gene Therapy, 2009, v. 16, n. 5, p. 462, doi. 10.1038/cgt.2008.91

By:

Dharmapuri, S.;
Aurisicchio, L.;
Neuner, P.;
Verdirame, M.;
Ciliberto, G.;
La Monica, N.

Publication type:

Article

CD4+CD25+ regulatory T-cell-inactivation in combination with adenovirus vaccines enhances T-cell responses and protects mice from tumor challenge.

Published in:

Cancer Gene Therapy, 2007, v. 14, n. 2, p. 201, doi. 10.1038/sj.cgt.7701004

By:

Elia, L.;
Aurisicchio, L.;
Facciabene, A.;
Giannetti, P.;
Ciliberto, G.;
La Monica, N.;
Palombo, F.

Publication type:

Article

Works by Ciliberto, G.

Electro-gene-transfer as a new tool for cancer immunotherapy in animals.

Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells.

Coronary artery disease after heart transplantation: non-invasive evaluation with exercise thallium scintigraphy.

High-dose dipyridamole echocardiography test in coronary artery disease after heart transplantation.

Echocardiographic assessment of cardiac allograft rejection.

CD8<sup>+</sup> T-Cell Tolerance can be Broken by an Adenoviral Vaccine While CD4<sup>+</sup> T-Cell Tolerance is Broken by Additional Co-administration of a Toll-Like Receptor Ligand.

Adenovirus Transduction and Culture Conditions Affect the Immunogenicity of Murine Dendritic Cells.

Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015.

In vivo hepatocyte proliferation is inducible through a TNF and IL-6-independent pathway.

High circulating levels of biologically inactive IL-6/SIL-6 receptor complexes in systemic juvenile idiopathic arthritis: evidence for serum factors interfering with the binding to gp130.

A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent.

Synergistic induction of growth arrest and apoptosis of human myeloma cells by the IL-6 super-antagonist Sant7 and Dexamethasone.

The Molecular Design of Human IL-6 Receptor Antagonistsa.

Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation.

Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2<sup>s</sup>-M2 tetracycline transactivator and repressor system.

Regulated and prolonged expression of mIFNα in immunocompetent mice mediated by a helper-dependent adenovirus vector.

Adenovirus-mediated gene transfer of a human IL-6 antagonist.

Risk Differences Between Prediabetes And Diabetes According To Breast Cancer Molecular Subtypes.

MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study.

Intratumor RNA interference of cell cycle genes slows down tumor progression.

Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives.

Validation of the European Oncology toolkit for the self-assessment of Quality of Life (EUonQoL-Kit) in cancer patients and survivors: study protocol of a pan European survey.

Efficacy and safety of 5% lidocaine-medicated plasters in localized pain with neuropathic and/or inflammatory characteristics: an observational, real-world study.

An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models.

CD4<sup>+</sup>CD25<sup>+</sup> regulatory T-cell-inactivation in combination with adenovirus vaccines enhances T-cell responses and protects mice from tumor challenge.